Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Welcome to Natera’s 2024 Third Quarter Financial Results ...

Researchers demonstrate AI-enhanced MRI's potential in diagnosing endometrial cancer, achieving superior accuracy and ...

At ESMO, we presented the results from the phase 3 NIAGARA trial ... is a inclusion of DESTINY-Breast06 into the guidelines. I think that that is a catalyst that is important to be able to really see ...